Zoetis Inc. (ZTS) Financial Statements (2024 and earlier)

Company Profile

Business Address 10 SYLVAN WAY
PARSIPPANY, NJ 07054
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments     99
Cash and cash equivalents      
Short-term investments      99
Restricted cash and investments 243225
Receivables1,3621,2861,1801,0611,1231,077
Inventory, net of allowances, customer advances and progress billings2,5642,3451,9231,6281,4101,391
Inventory2,5642,3451,9231,6281,4101,391
Other current assets434365389366318271
Other undisclosed current assets 1,9813,5063,4353,5541,8951,556
Total current assets:6,3437,5066,9306,6114,7484,399
Noncurrent Assets
Operating lease, right-of-use asset230220181192189
Property, plant and equipment3,2042,7532,4222,2021,9401,658
Intangible assets, net (including goodwill)4,0974,1264,1564,4044,4824,565
Goodwill2,7592,7462,6822,6942,5922,519
Intangible assets, net (excluding goodwill)1,3381,3801,4741,7101,8902,046
Deferred income tax assets20617310094 
Other noncurrent assets2061471111069894
Other undisclosed noncurrent assets     8861
Total noncurrent assets:7,9437,4196,9706,9986,7976,378
TOTAL ASSETS:14,28614,92513,90013,60911,54510,777
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,0941,0871,7301,4731,2511,180
Interest and dividends payable1541199579
Taxes payable38463635
Employee-related liabilities392295276266
Accounts payable411405436457301313
Accrued liabilities683682710556543487
Debt41,352 6045009
Other liabilities1029767935534
Other undisclosed current liabilities 689631    
Total current liabilities:1,8893,1671,7972,1701,8061,223
Noncurrent Liabilities
Long-term debt and lease obligation6,5646,5526,7436,7586,1116,443
Long-term debt, excluding current maturities6,5646,5526,5926,5955,9476,443
Liabilities, other than long-term debt842803816908509926
Accounts payable and accrued liabilities271258257260257265
Asset retirement obligations     23 
Deferred tax liabilities, net474
Deferred income tax liabilities146142320378 
Other liabilities237217239270229187
Operating lease, liability188186151163164
Other undisclosed noncurrent liabilities     411 
Total noncurrent liabilities:7,4067,3557,5597,6667,0317,369
Total liabilities:9,29510,5229,3569,8368,8378,592
Equity
Equity, attributable to parent4,9974,4054,5433,7692,7082,185
Common stock555555
Treasury stock, value(5,597)(4,539)(2,952)(2,230)(2,042)(1,487)
Additional paid in capital1,1331,0881,0681,0651,0441,026
Accumulated other comprehensive loss(839)(817)(764)(730)(726)(629)
Retained earnings10,2958,6687,1865,6594,4273,270
Equity, attributable to noncontrolling interest(6)(2)14  
Total equity:4,9914,4034,5443,7732,7082,185
TOTAL LIABILITIES AND EQUITY:14,28614,92513,90013,60911,54510,777

Income Statement (P&L) ($ in millions)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues8,5448,0807,7766,6756,2605,825
Cost of revenue
(Cost of Goods and Services Sold)
(2,561)(2,454)(2,303)(2,057)(1,992)(1,911)
Gross profit:5,9835,6265,4734,6184,2683,914
Operating expenses(2,765)(2,548)(2,509)(2,189)(2,095)(1,916)
Operating income:3,2183,0782,9642,4292,1731,998
Nonoperating income (expense)159(40)(48)(17)5783
Investment income, nonoperating37410121628
Loss, foreign currency transaction, before tax(47)(62)(27)(21)(16)(31)
Other nonoperating income (expense)(1)14(4)(5) 15
Interest and debt expense(239)(221)(224)(231)(223)(206)
Income from continuing operations before equity method investments, income taxes:3,1382,8172,6922,1812,0071,875
Other undisclosed loss from continuing operations before income taxes(202)(161)(204)(185)(206)(185)
Income from continuing operations before income taxes:2,9362,6562,4881,9961,8011,690
Income tax expense(596)(545)(454)(360)(301)(266)
Income from continuing operations:2,3402,1112,0341,6361,5001,424
Income before gain (loss) on sale of properties:2,0341,6361,5001,424
Net income:2,3402,1112,0341,6361,5001,424
Net income attributable to noncontrolling interest4332 4
Net income available to common stockholders, diluted:2,3442,1142,0371,6381,5001,428

Comprehensive Income ($ in millions)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income:2,3402,1112,0341,6361,5001,424
Other comprehensive loss(22)(53)(34)(4)(97)(124)
Comprehensive income:2,3182,0582,0001,6321,4031,300
Comprehensive income, net of tax, attributable to noncontrolling interest4332 4
Comprehensive income, net of tax, attributable to parent:2,3222,0612,0031,6341,4031,304

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: